Motif Neurotech, a neurotechnology startup, has garnered FDA approval to initiate a feasibility trial for a novel brain implant designed to address depression.
This approval allows the company to explore the potential of its innovative approach in treating a condition that affects millions.
The trial will assess the safety and efficacy of the brain implant, potentially paving the way for new treatment options in mental health care.